Future Outlook And Stock Price Trends Among Heron Therapeutics Inc Stocks (NASDAQ: HRTX)

In the last trading session, 2.09 million shares of the Heron Therapeutics Inc (NASDAQ:HRTX) were traded, and its beta was 1.68. Most recently the company’s share price was $2.59, and it changed around -$0.05 or -1.89% from the last close, which brings the market valuation of the company to $389.35M. HRTX currently trades at a discount to its 52-week high of $3.22, offering almost -24.32% off that amount. The share price’s 52-week low was $0.50, which indicates that the current value has risen by an impressive 80.69% since then. We note from Heron Therapeutics Inc’s average daily trading volume that its 3-month average coming to 2.61 million.

Heron Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended HRTX as a Hold, whereas 8 deemed it a Buy, and 0 rated it as Underweight. Heron Therapeutics Inc is expected to report earnings per share of $Vertex Pharmaceuticals Incorpor for the current quarter.

Heron Therapeutics Inc (NASDAQ:HRTX) trade information

Instantly HRTX has showed a red trend with a performance of -1.89% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 52.35% year-to-date, but still down -12.20% over the last five days. On the other hand, Heron Therapeutics Inc (NASDAQ:HRTX) is -15.08% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $5, which translates to bulls needing to increase their stock price by 48.2% from its current value. Analyst projections state that HRTX is forecast to be at a low of $5 and a high of $5.

Heron Therapeutics Inc (HRTX) estimates and forecasts

Heron Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 306.40 percent over the past six months and at a 72.50% annual growth rate that is well above the industry average of 10.20%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 20.01%. Heron Therapeutics Inc earnings are expected to increase by 73.39% in 2024, but the outlook is positive 47.50% per year for the next five years.